Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStar Energy Regulatory News (STAR)

Share Price Information for Star Energy (STAR)

Share Price is delayed by 15 minutes
Get Live Data
19.00    0.40 (2.11%)
Bid:
18.00
Ask:
20.00
Spread: 2.00 (11.111%)
Market Cap: £37.37m
STAR Live PriceLast checked at - London Stock Exchange

Intraday Star Energy Share Chart

Year End Trading Update

10 Feb 2021 07:00

RNS Number : 5335O
Starcom PLC
10 February 2021
Β 

This announcement contains inside information for the purposes of Regulation 11 of the Market Abuse (amendment) (EU Exit) Regulations 2019/310.

Β 

10 February 2021

Β 

Starcom PLC

("Starcom" or the "Company")

Β 

Year End Trading Update

Β 

The Board of Starcom (AIM: STAR), which specialises in the development of wireless, Internet-Of-Things (IoT) based solutions for the remote tracking, monitoring and protection of a variety of assets, is pleased to provide the following trading update for the year ended 31 December 2020 ("FY 2020") and an update on the Company's prospects for the current year. The Company expects to announce its audited results for the year ended 31 December 2020 in early March 2021.

Β 

The results for FY 2020 reflect the global impact of Covid-19 on the Company. The Company's preliminary unaudited accounts for 2020 show revenue of approximately $5 million (2019: $6.8 million), gross margin of 33% (2019: 41%) and an adjusted EBITDA* loss of approximately $350,000 (2019: profit $296,000).

Β 

The Company responded promptly to the Covid-19 crisis and reduced its overheads by approximately 10% compared with 2019. R&D expenses, however, were only reduced by a small amount to maintain investment and development in the Company's technologies. Margins were impacted by costs of amortisation and high logistics and shipment costs as a result of the pandemic, as capacity was reduced. As announced previously, due to the disruption caused by the pandemic, many of the Company's customers were unable to place orders and make payments as expected in 2020. The final results for FY2020 will therefore include appropriate provisions in respect of delays in payments by some customers who could not meet their obligations to Starcom.

Β 

The Company has been successful in securing a low-cost long-term bank loan as well as government grants to mitigate the effects of the pandemic, and the resulting and unexpected cashflow pressure.

Β 

It is encouraging to see that, even in such a challenging year, the Company could still rely on its strong and loyal customer base to generate $2.2 million of SaaS revenues, an increase of approximately 9% compared to the previous year. Although hardware sales were severely depressed by the pandemic at $2.8 million, the newer and higher margin products - Kylos, Tetis and Lokies - still represented 40% of hardware sales. This included the second production batch of Lokies, which were well received by the customers.

Β 

Even during the long lock-down periods, the Company continued to maintain and further develop Starcom's strategic alliances and pipeline of potential projects. For example, work with Zero Motorcycles ("Zero") progressed during 2020 to ensure Starcom's technology can support Zero's new generation of motorcycles.

The Company is hoping to benefit from the new opportunities that the global vaccination effort presents within the logistics industry, most significantly, the need to monitor the temperature and other conditions of vaccines whilst in transit. The Company is already involved in discussions with two potential customers who provide vaccine logistics services.

Β 

Avi Hartmann, CEO of Starcom, commented, "I am pleased with the way Starcom has been able to cope with the impact of the pandemic. We have adjusted our costs quickly, secured financial resources to ensure business continuity, and in parallel, focused on retaining our key assets, mainly our solid client base and pipeline of future opportunities. I am particularly proud of our recurring SaaS revenues that grew this year despite the pandemic. I remain optimistic about Starcom's ability to return to growth as the market returns to normality."

Β 

*Adjusted EBITDA is earnings before interest, tax, depreciation, and amortization and excluding one-off charges and share based payments.

Β 

-ends-

Β 

For further information please contact:

Β 

Starcom Plc

Michael Rosenberg, Chairman

Avi Hartmann, CEO

Β 

Β 

07785 727595

+972 5477 35663

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Jeremy Porter/Asha Chotai

Β 

020 3328 5656

Peterhouse Capital Limited (Joint Broker)

Lucy Williams/Charles Goodfellow/Eran Zucker

Β 

020 7469 0930

Leander PR (Financial PR)

Christian Taylor-Wilkinson

Β 

07795 168 157

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFLFFTFRIAIIL
Date   Source Headline
28th May 20269:43 amRNSDirector/PDMR Shareholding
26th May 20267:00 amRNSExercise of Options and Total Voting Rights
21st May 20264:56 pmRNSHolding(s) in Company
21st May 20264:55 pmRNSHolding(s) in Company
21st May 20262:40 pmRNSHolding(s) in Company
21st May 202612:05 pmRNSBlock Listing Application
19th May 202610:46 amRNSHolding(s) in Company
18th May 202612:43 pmRNSResult of General Meeting and Total Voting Rights
7th May 20267:00 amRNSResult of Retail Offer
1st May 20267:01 amRNSProposed Retail Offer to raise up to £0.6 million
1st May 20267:00 amRNSResult of Fundraising and Notice of GM
30th Apr 20264:58 pmRNSLaunch of Placing, Subscription and Retail Offer
30th Apr 20262:53 pmRNSAdditional Listing Director/PDMR Shareholding
29th Apr 20267:00 amRNSHolding(s) in Company
29th Apr 20267:00 amRNSFinal Results
24th Apr 202611:34 amRNSSale of Croatian geothermal company
8th Apr 20262:35 pmRNSHolding(s) in Company
25th Feb 20267:00 amRNSTrading Update
29th Jan 20267:00 amRNSAdditional Listing Director/PDMR Shareholding
19th Dec 20259:57 amRNSBlock Listing Six Monthly Return
19th Dec 20259:57 amRNSBlock Listing Six Monthly Return
8th Dec 20252:30 pmRNSTotal Voting Rights
5th Dec 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
17th Nov 202510:50 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSAdditional Listing Director / PDMR Shareholding
22nd Sep 202511:18 amRNSHolding(s) in Company
19th Sep 20254:37 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
16th Sep 20257:00 amRNSHalf-year Report
5th Aug 20257:00 amRNSAdditional Listing Director/PDMR Shareholding
23rd Jun 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
20th Jun 20257:00 amRNSBlock Listing Six Monthly Return
19th Jun 202512:29 pmRNSResult of AGM
19th Jun 20257:00 amRNS2025 Annual General Meeting Trading Update
10th Jun 20257:00 amRNSTotal Voting Rights
3rd Jun 20251:02 pmRNSForm 8.3 - Dowlais Group plc
3rd Jun 20251:00 pmRNSForm 8.3 - Qualcomm Incorporated
21st May 20251:16 pmRNSAnnual Report & Notice of Annual General Meeting
16th May 20257:00 amRNSGrant of Awards under Management Retention Plan
6th May 20257:00 amRNSPartnership with Veolia - Geothermal Projects
2nd May 20257:00 amRNSAdditional Listing Director/PDMR Shareholding
29th Apr 20257:00 amRNSFinal Results
22nd Apr 20256:00 pmRNSCompletion of Sale of Non-core Asset
8th Apr 20254:22 pmRNS-RReserves & Resources Update
31st Mar 20257:00 amRNS-RMoU with Bring Energy
6th Mar 20257:00 amRNSGrant of Awards
28th Feb 20252:11 pmRNS-RInvestor Presentation
24th Feb 20257:00 amRNSTrading Update
5th Feb 20257:00 amRNSTotal Voting Rights
30th Jan 20257:00 amRNSAdditional Listing Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.